{"entity":{"id":"sandra-demaria","kind":"person","name":"Sandra Demaria","aka":[],"tldr":"Weill Cornell pathologist-immunologist known for radiation-immunotherapy research; SITC Vice President.","summary":"Sandra Demaria is Vice President of the Society for Immunotherapy of Cancer for 2025-2026 and a professor at Weill Cornell Medicine. Her laboratory studies how radiotherapy modulates anti-tumour immunity and how it can be combined with immune checkpoint blockade, with a strong focus on breast cancer. She is a widely cited contributor to the field of radiation-induced in situ vaccination.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.sitcancer.org/about/board"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Demaria+S%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","immunotherapy","radiotherapy"],"related":[],"cancers":["breast-hr-positive","tnbc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sitc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Vice President (2025-2026)","institutionId":"sitc","specialisms":["Radiation and immunotherapy combinations","Tumour immunology","Breast cancer"],"profiles":[{"label":"Society page","url":"https://www.sitcancer.org/about/board"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Demaria+S%5BAuthor%5D"}],"papers":[{"title":"Role of Local Radiation Therapy in Cancer Immunotherapy","journal":"JAMA Oncology","year":2015,"doi":"10.1001/jamaoncol.2015.2756"},{"title":"Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift","journal":"JNCI: Journal of the National Cancer Institute","year":2013,"doi":"10.1093/jnci/djs629"},{"title":"Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells","journal":"The Journal of Immunology","year":2008,"doi":"10.4049/jimmunol.181.5.3099"}],"orcid":"0000-0003-4426-0499"},"route":"/people/sandra-demaria/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"institution":[{"id":"sitc","kind":"institution","name":"Society for Immunotherapy of Cancer","route":"/institutions/sitc/"}]}}